Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Biostar Pharmaceuticals (BSPM) Share Price

News articles about Biostar Pharmaceuticals (NASDAQ:BSPM) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Biostar Pharmaceuticals earned a news sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the company an impact score of 45.1091193270698 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Shares of Biostar Pharmaceuticals (NASDAQ:BSPM) traded up $0.11 during midday trading on Friday, reaching $2.01. 253,700 shares of the company’s stock were exchanged, compared to its average volume of 95,967. The company has a market cap of $5.01, a P/E ratio of 2.87 and a beta of 1.87. Biostar Pharmaceuticals has a one year low of $1.18 and a one year high of $4.30.

Biostar Pharmaceuticals (NASDAQ:BSPM) last posted its earnings results on Wednesday, November 15th. The company reported ($0.50) earnings per share for the quarter. During the same period in the previous year, the company posted ($3.12) EPS.

WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Biostar Pharmaceuticals (BSPM) Share Price” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3127221/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-biostar-pharmaceuticals-bspm-share-price.html.

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).

Insider Buying and Selling by Quarter for Biostar Pharmaceuticals (NASDAQ:BSPM)

Receive News & Ratings for Biostar Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.